Pharmafile Logo
Pharmafocus logo
Advanced Search

Boehringer blood cancer drug scores in Phase II

July 9, 2014
Research and Development, Sales and Marketing Boehringer, blood, giotrif, leukaemia, volasertib

Less than a year after securing its first cancer drug on the market with Giotrif, Boehringer has taken another decisive …

News
Shire image

AbbVie makes fourth Shire offer

July 9, 2014
Sales and Marketing AbbVie, Abbott, Shire, buyout, merger

The AbbVie/Shire takeover saga rumbles on, with AbbVie raising its bid for the Ireland-based biopharma specialist to $51.5 billion. The …

News
sarah_newman

Clark Health Communications hires account director

July 9, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Clark Health Communications, chc, newman

Clark Health Communications (CHC) has recruited account director Sarah Newman as its first full-time employee to help manage the agency’s …

Appointment
Telemedicine image

Telemedicine EU market ‘expected to triple’ by 2020

July 8, 2014
Medical Communications, Sales and Marketing Europe, Frost & Sullivan, analysts, telemedicine

The telemedicine market in Europe is poised for rapid growth and can help keep overall healthcare costs down, according to …

News

UDG Healthcare buys Galliard and Nyxeon for £13m

July 8, 2014
Medical Communications Galliard and Nyxeon, udg healthcare

UDG Healthcare has acquired the specialist healthcare and scientific public relations businesses Galliard and Nyxeon. The deal has been secured …

News

Cameron’s antibiotics plan not enough

July 8, 2014
Research and Development, Sales and Marketing Antibiotics, BBC, NHS, UK, david cameron, governement

UK prime minister David Cameron’s reaction to antibiotic resistance is not urgent enough and doctors are continuing to prescribe antibiotics …

News
BMS image

World’s first anti-PD-1 therapy approved

July 8, 2014
Research and Development, Sales and Marketing BMS, Cancer, melanoma, nivolumab, ono, opdivo

Ono Pharmaceutical has been given the world’s first licence for a new type of cancer treatment on which many researchers’ …

News
ian_dodge_nhs

New appointments at NHS England

July 8, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing DoH, NHS Commissioning, NHS England, stevens

NHS England chief executive Simon Stevens has confirmed a number of senior appointments to the organisation. Dr Mahiben Maruthappu has …

Appointment
GSK image

GSK manufacturing woes continue

July 8, 2014
Manufacturing and Production Canada, FDA, GSK, Paxil, Vaccine, manufacturing

Health Canada has told GlaxoSmithKline that it wants to see the firm fix major problems at the country’s only flu …

News
Xellia image

Xellia expands in US with Fresenius Kabi buy

July 8, 2014
Manufacturing and Production Fresenius Kabi, xellia

Anti-infective treatment provider Xellia has acquired Fresenius Kabi’s dedicated freeze-dried vial manufacturing facility in the US.  The deal also includes …

News
Celgene image

Scottish Medicines Consortium disappoints Celgene

July 8, 2014
Sales and Marketing Celgene, SMC, Scottish Medicines Consortium, imnovid, myeloma

Celgene admitted it is ‘disappointed’ with the Scottish Medicines Consortium decision not to recommend blood cancer therapy Imnovid for patients …

News
marie_innes_1

New director for Cello Health Insight

July 8, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cello, Kantar Health, marie innes

Healthcare market research agency Cello Health Insight has appointed Marie Innes as director. Based in the firm’s London head office …

Appointment

Rise in diabetes ‘alarming’

July 7, 2014
Sales and Marketing NHS, diabetes, nhs scotland, type 2

NHS Scotland has spent around £230 million on diabetes and obesity drugs in the past three years, according to data …

News
gsk image

Mekinist shown EU green light

July 7, 2014
Sales and Marketing CHMP, Cancer, GSK, Tafinlar, braf, mekinist, melanoma

The European Commission has given GlaxoSmithKline’s melanoma drug Mekinist the thumbs-up following a positive opinion in April from the European …

News
amy_schulman_alynlam

Alynlam secures fomer Pfizer head

July 7, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pfizer, alynlam, amy schulman

US biotech firm Alynlam has elected Pfizer’s former executive VP and general counsel Amy Schulman to its board of directors. …

Appointment
Roche image

Roche lung cancer drug sees first approval

July 4, 2014
Sales and Marketing ALK+, Cancer, NSCLC, Pfizer, Roche, Xalkori, alectinib, alk, zykadia

Roche has seen the first approval for its new lung cancer drug alectinib in Japan as it looks to compete …

News
FDA image

Spectrum wins FDA approval for rare cancer drug

July 4, 2014
Research and Development, Sales and Marketing Beleodaq, Cancer, FDA, Spectrum, non-Hodgkin lymphoma

In an expedited review the FDA has approved a new cancer drug from Spectrum Pharmaceuticals to treat a rare cancer …

News
st jude image

FDA clears St. Jude Medical

July 4, 2014
Manufacturing and Production, Sales and Marketing CardioMEMS, FDA, california, st jude medical

US medical device manufacturer St. Jude Medical has been given a clean bill of health by the Food and Drug …

News
NHS image

Unison warns of ‘dangerous’ £1 billion NHS tender

July 4, 2014
Sales and Marketing CCG, England, NHS, commissioning, unison

A row is bubbling over the provision of health services in Staffordshire after a trade union accused four NHS clinical …

News
ann-tove_kongsnes_

Pharmalink elects three to board

July 4, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ann-Tove Kongsnes, Hilde Furberg, Olav Hellebø, Pharmalink, ab

Swedish speciality pharma firm Pharmalink AB has appointed Ann-Tove Kongsnes, Hilde Furberg and Olav Hellebø to its board of directors. …

Appointment
The Gateway to Local Adoption Series

Latest content

Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases

January 28, 2026

Everdrone appoints David Borkmann as Senior Medical Advisor

January 28, 2026

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026